Cases
Representative Work: Acted for Telesystem Ltd, the majority shareholder of NorthStar Earth
Space Inc., on their C$52 million financing with the Governments of Canada
Quebec, as well as from strategic partners Telesystem Space Inc.
the Space Alliance of Europe.
Acted for Cuda Energy Inc. in its strategic combination with Junex Inc. by way of plan of arrangement.
Acted for a syndicate of underwriters led by TD Securities Inc., CIBC World Markets Inc., BMO Nesbitt Burns Inc., National Bank Financial Inc.,
including RBC Dominion Securities Inc., Desjardins Securities Inc., Canaccord Genuity Corp., Industrial Alliance Securities Inc.
Raymond James Ltd. in the context of a $150,000,000 bought deal of convertible unsecured subordinated debentures of Innergex Renewable Energy Inc.
Acted for Ressources Quebec Inc., acting as m
atary of the government of Quebec, in the context of the private placement of common shares in Nemaska Lithium Inc., which formed part of an overall $1.1B project financing package.
Acted for the Caisse de depot et placement du Quebec, lead investor, in the context of a $20,000,000 round of financing in Frank & Oak, alongside Investissement Quebec
Goodwater Capital.
Acted for the Caisse de depot et placement du Quebec in a $7,000,000 venture capital equity investment in TrackTik Software Inc.
Acted for the Caisse de depot et placement du Quebec in a $2,500,000 venture capital equity investment in Groupe Glutenberg Inc., a producer
distributor of gluten-free craft beers
spirits.
Acted for the Caisse de depot et placement du Quebec in an $80,000,000 investment in eStruxture Holdings Inc.
Acted for Servier Canada, in the context of their $21,000,000 investment along with Fonds de solidarite FTQ
CTI Life Sciences Fund to create ILKOS THERAPEUTICS inc., a new Quebec biotechnology firm.
Acted for Ressources Quebec Inc. in the context of a $10,000,000 private placement of units of Falco Resources Ltd., a TSX Venture Exchange listed issuer.
Acting for CiToxLAB Group Inc. in connection with its acquisition of AccelLAB Inc.
Acting for Kinross Gold Corporation in the option to acquire a 100% interest in Yorbeau's Rouyn Property from Yorbeau Resources Inc.
Acted for ProMetic Life Sciences Inc., a Toronto Stock Exchange listed issuer, in connection with the closing of a bought deal public offering of 19,400,000 common shares, conducted through a syndicate of underwriters, for aggregate gross proceeds of $60,140,000
the concurrent private placement entered into with Structured Alpha LP, for the subscription of 1,921,776 common shares.
Acted for Ressources Quebec Inc. in the context of a $10,000,000 private placement of units of Nemaska Lithium Inc., a TSX Venture Exchange listed issuer.
Acted for sponsors in an investment in the iNovia Investment Fund III.
Represented Iluka Exploration (Canada) Ltd., a wholly-owned subsidiary of Iluka Resources Limited, in the negotiation
conclusion of an option
joint venture agreement with Societe d'Exploration Miniere Vior Inc., a TSX Venture Exchange listed issuer.
Acted for Bluestreak Technologies (Canada) Inc. in the context of the sale of its assets to Espial Group Inc.
Acting for Sulliden Mining Capital Inc. in the option of the Troilus Mine from First Quantum Minerals Ltd.
Acted for the underwriters in the context of a bought deal offering under a short form prospectus of convertible unsecured subordinated debentures of Innergex Renewable Energy Inc. for an aggregate principal amount of $100 million.
Represented Diagnos Inc., a TSX Venture Exchange listed issuer, in the context of a private placement of senior secured convertible debentures through a syndicate of agents.
Acted for Qwave Capital LLC, a U.S. based private equity firm, in connection with its $17 million unsolicited take-over bid on the TSX Venture Exchange listed online lending company, IOU Financial Inc.
Represented Teralys Capital, a fund manager financing private venture capital funds, in the context of their investments in White Star Capital Canada Limited Partnership, Persistence Capital Partners II, L.P., Sofinnova Capital VIII
Versant Venture Capital VI, L.P.
Acted for ProMetic Life Sciences Inc., a Toronto Stock Exchange listed issuer, in connection with the closing of a bought deal public offering of 19,250,000 common shares, conducted through a syndicate of underwriters, for aggregate gross proceeds of $50,050,000.
Acted for Groupe Bikini Village Inc. in the context of the sale of substantially all of its assets to Boutique La Vie en Rose Inc.
Represented MRRM Inc. in the context of its going-private transaction
amalgamation with a wholly-owned subsidiary of Marbour S.A.S.
Acted for ProMetic Life Sciences Inc. in connection with the closing of a bought deal public offering of 13,200,000 common shares, conducted through a syndicate of underwriters, for aggregate gross proceeds of $25,080,000.
Represented Diagnos Inc. in connection with the amalgamation of one of its wholly-owned subsidiaries with Warnex Inc.
Represented BDC Venture Capital
Investissement Quebec in the context of their investment in White Star Capital, a transatlantic seed vehicle based in Guernsey investing in start-up companies in the fields of social media, gaming
e-commerce.
Acted as Canadian counsel to Strides Arcolab Limited in the context of the sale of their Agila Specialties Pharma Corporation business to Mylan Inc. for a total consideration of up to US$1.75 billion.
Acted for ProMetic Life Sciences Inc. in connection with the closing of their public offering of a total to 26,651,400 common shares conducted on a best efforts basis by a syndicate of agents, for total gross proceeds of $23,986,260.
Represented BDC Venture Capital in the context of their investment in Br
Project LP, a new venture that invests in early-stage consumer products
technology companies, as well as in the context of their investment in T
emLaunch, ideation company that invests in emerging consumer electronics
multimedia technologies.
Advised Klox Technologies Inc. in the context of the sale of its in-office whitening kit
teeth-whitening pen businesses to Valeant Pharmaceuticals International, Inc.
Represented Empire Maintenance Industries in connection with the sale of all of its issued
outst
ing shares to Birch Hill Equity Partners.
Advised management of Global Railway Industries in the context of the management buy-out of CAD Railway Industries.
Acted for Blue Note Mining Inc., a Canadian mineral exploration
mining company headquartered in Montreal, in the context of the spinoff of its New Brunswick mining properties to GeoVenCap Inc., a capital pool company.
Acted for Applied Biology Company, parent company of CIT Safety & Health Research Company, in the context of its acquisition of substantially all assets of LAB Research Inc.
Represented Tetra Tech, Inc., a global consulting, engineering
construction firm based in Pasadena, California
listed on the NASDAQ, in the context of the acquisition of BPR, one of the largest independent engineering services firms in Canada.
Acted for Groupe Bikini Village Inc., a Toronto Stock Exchange listed issuer, in the context of a rights offering
a concurrent private placement.
Represented ProMetic Life Sciences Inc. in the context of a financing deal with U.S.-based Abraxis BioScience, Inc. for a total of US$13,000,000.
Acted for Blue Note Mining Inc. in the context of its acquisition of X-Ore Resources Inc.
Represented Blue Note Mining Inc. during its successful $56 million restructuring
listing on the TSX Venture Exchange.
Advised Uniprix Inc.'s board of directors in connection with an offer from McKesson Canada to purchase all outst
ing shares of Uniprix.
Represented ProMetic Life Sciences Inc. in the context of its final agreements with Abraxis BioScience, Inc. for the development
marketing on a world-wide basis (excluding China
Taiwan) of four biopharmaceutical products targeting underserved medical conditions.
Advised BriseboisCo in the context of its privatization of Isacsoft Inc, a provider of software business solutions.
Acted for ProMetic Life Sciences Inc. in the context of prospectus offerings of 60,230,357 Subordinate Shares for total proceeds of $19,719,375.
Represented CTI Capital Inc., acting as agent in connection with Petrolympia' initial public offering in the context of its qualifying transaction with Pisces Capital Corp.
Acted for DEQ Systems Corp. in the context of a prospectus offering of 15,000,000 units for total proceeds $6,000,000.
Acted for Ambrilia Biopharma Inc. in the context of its brokered offering of 78,677,841 Units for total proceeds of $18,100,000.
Advised Alimentation Couche-Tard Inc. in the context of its brokered offering of 4,000,000 shares for total proceeds of $101,600,000.
Represented SITQ Immobilier in the context of its acquisition of all issued
outst
ing shares of Bentall Corporation for $780 million.
Represented BMO Nesbitt Burns Inc.
CIBC World Markets Inc., acting as dealer managers in the context of the rights offering of Canbras Communications Corp. for a total of $99,105,209.
Acted for Teleglobe in connection with the sale of its outst
ing 78.4% public interest to BCE for a total consideration of $8,374,657,733.
